BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United Kingdom), United Kingdom, covering academic research published from 2010 to 2024. Read More.
Open Access Percentage
79%
Total
Publications
107
Total Open
Publications
84
Total
Citations
2K
Open Access
Percentage
79%
Total
Publications
107
Total Open
Publications
84
Total
Citations
2K
Breakdown
Publisher Open
28%
Both
49%
Other Platform Open
2%
Closed
21%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 50%
41
Hybrid 48%
39
No Guarantees 2%
2
Other Platform Open
Domain 83%
45
Institution 30%
16
Other Internet 4%
2
Preprint 2%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 43 |
University College London - UCL Discovery | Institution | 8 |
Europe PMC | Domain | 8 |
University of California - eScholarship University of California | Institution | 5 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
University of Birmingham - University of Birmingham Research Portal | Institution | 2 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 2 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 2 |
Australian National University - ANU Open Research | Institution | 2 |
AECID Library - Americanae | Institution | 2 |